As a registered charity and an independent company, The Pirbright Institute is governed by a Board of non-executive Trustee Directors. The Institute has appointed two new Trustees for 2022: Professor Deenan Pillay and Professor Mike Turner. The new Trustees are joining the Trustee Board to broaden...
Scientists at The Pirbright Institute have identified key differences in the immune response of chickens that are resistant to Marek’s disease, and those that are not. This research could pave the way for the development of more effective vaccines against this serious disease. In a recent paper...
The Pirbright Institute is taking a lead role in a new monkeypox consortium. The group will work together to develop better diagnostic tests, identify potential therapies and study vaccine effectiveness and the virus’ spread. The Monkeypox Consortium has received £2million investment from the...
The Pirbright Institute joins the nation and rest of the world in mourning the loss of Her Majesty Queen Elizabeth II. For more than seven decades she dedicated herself to public service, and inspired others globally. Prof Bryan Charleston, Director of The Pirbright Institute said “Her majesty was...
Seven of Pirbright’s scientists have had upcoming projects funded by UKRI through the BBSRC Impact Acceleration Account (IAA). These scientists have several qualities in common: scientific know-how, experience in leading projects, and the fact they are all women. The IAA helps scientists create...
Pirbright's longstanding expertise in viral diseases is helping us to provide vital services and information that will help to tackle the life changing pandemic caused by COVID-19.
Our Coronavirus Hub provides an overview of how the Institute is aiding the pandemic response, including Pirbright's COVID-19 research on vaccines, understanding how the virus works, and exploring diagnostic solutions, as well as the support we are providing to the UK diagnostic effort.
We work collaboratively with stakeholders globally, including research and academic institutions, government ministries and agencies, multilateral organisations, non-government organisations (NGOs) that range from big international charities to local advocacy groups, as well as philanthropic foundations and commercial companies.
Our innovative research into viruses of farm animals and those that spread from animals to people is possible with new state-of-the-art facilities including the BBSRC National Virology and Vaccinology Centres. Find out more about our campus.
® The Pirbright Institute 2022 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.
